Latest industry developments against COVID-19
In the face of the threat from the novel coronavirus, industry momentum is gathering to produce a solution.
Archives for March 30, 2020
J&J chooses lead coronavirus candidate, sets up manufacturing for 1 billion doses
The company provides update on its coronavirus plans, which includes $1bn in funding to research and expected Phase I trial commencement date.
Takeda taps Evox for exosome therapeutics
The partners will focus on developing five potential exosome treatment for rare diseases.
Novartis’ gene therapy takes additional step towards EU approval
Zolgensma has received a recommendation for approval despite running into problems recently, including manufacturing questions and data integrity issues.